| 期刊論文| 1. | Becker, Michael A.、Schumacher, H. Ralph Jr.、Wortmann, Robert L.、MacDonald, Patricia A.、Eustace, Denise、Palo, William A.、Streit, Janet、Joseph-Ridge, Nancy(2005)。Febuxostat compared with allopurinol in patients with hyperuricemia and gout。The New England Journal of Medicine，353(23)，2450-2461。   | | 2. | Goldfarb, D. S.、MacDonald, P. A.、Hunt, B.、Gunawardhana, L.(2011)。Febuxostat in gout: serum urate response in uric acid overproducers and underexcretors。Journal of Rheumatology，38，1385-1389。 | | 3. | Rider, T. G.、Jordan, K. M.(2010)。The modem management of gout。Rheumatology，49，5-14。 | | 4. | Wilson, J. F.(2010)。In the clinic: Gout。Annals of Internal Medicine，152(3)。 | | 5. | Kamatani, N.、Fujimori, S.、Hada, T.、Hosoya, T.、Kohri, K.、Nakamura, T.(2011)。An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study。Journal of Clinical Rheumatology，17(4)，S44-S49。 | | 6. | Kamatani, N.、Fujimori, S.、Hada, T.、Hosoya, T.、Kohri, K.、Nakamura, T.(2011)。An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study。Journal of Clinical Rheumatology，17(4)，S13-S18。 | | 7. | Becker, M. A.、Schumacher, H. R.、MacDonald, P. A.、Lloyd, E.、Lademacher, C.(2009)。Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout。Journal of Rheumatology，36，1273-1282。 | | 8. | Schumacher, H. R.、Becker, M. A.、Wortmann, R. L.、Macdonald, P. A.、Hunt, B.、Streit, J.(2008)。Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial。Arthritis & Rheumatology，59，1540-1548。 | | 9. | Becker, M. A.、Schumacher, H. R.、Espinoza, L. R.、Wells, A. F.、MacDonald, P.、Lloyd, E.(2010)。The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial。Arthritis Research & Therapy，12(2)。 | 圖書| 1. | 中華民國風濕病醫學會、國家衛生研究院衛生政策研發中心(2007)。臺灣痛風與高尿酸血症診療指引。臺中：中華民國風濕病醫學會。 延伸查詢 | |